Skip to main content
. 2018 Jan 16;13(1):e0190540. doi: 10.1371/journal.pone.0190540

Fig 3. Experimental plan designed to test the action of liposomes loaded with the anti-angiogenic agent fumagillin in early atherosclerotic lesions.

Fig 3